Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI

European Journal of Radiology

Volumn 83, Issue 7, 2014, Pages 1245-1249

  Khouri Chalouhi, Katia ^b   Papini, Giacomo D E ^a   Bandirali, Michele ^b   Sconfienza, Luca M ^a,b   Di Leo, Giovanni ^a   Sardanelli, Francesco ^a,b  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Brain MRI; Contrast material dose; Contrast enhanced MRI; Gadobenate dimeglumine; Gadoterate meglumine

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOTERATE MEGLUMINE; CONTRAST MEDIUM; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERNAL CAROTID ARTERY; MALE; MENINGIOMA; NEURILEMOMA; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PAROTID GLAND; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; VESTIBULOCOCHLEAR NERVE; ANALOGS AND DERIVATIVES; BRAIN TUMOR; COMPARATIVE STUDY; DIAGNOSTIC USE; DOSE RESPONSE; IMAGE ENHANCEMENT; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

BRAIN NEOPLASMS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84902174906     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2014.03.030     Document Type: Article

References (16)

1. J.G. Smirniotopoulos, F.M. Murphy, and E.J. Rushing Patterns of contrast enhancement in the brain and meninges Radiographics 27 2007 525 551
2. F.L. Giesel, A. Mehndiratta, and M. Essig High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review Eur Radiol 20 2010 2461 2474
3. O. Bruder, S. Schneider, and D. Nothnagel Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry JACC Cardiovasc Imaging 4 2011 1171 1176
4. H.S. Thomsen, S.K. Morcos, and T. Almén et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. ESUR Contrast Medium Safety Committee Eur Radiol 23 2013 307 318
5. M. Essig, A. Tartaro, and T. Tartaglione Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators Acad Radiol 13 2006 744 751
6. F.M. Cavagna, F. Maggioni, and P.M. Castelli Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging Invest Radiol 32 1997 780 796
7. J. Pintaske, P. Martirosian, and H. Graf et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla Invest Radiol 41 2006 213 221
8. G. Schneider, R. Maas, and L. Schultze Kool et al. Low dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver Invest Radiol 2003 85 94
9. V.M. Runge, J.R. Parker, and M. Donovan Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain Invest Radiol 37 2002 269 280
10. C. Colosimo, M.V. Knopp, and X. Barreau et al. A comparison of Gd-BOPTA and Gd-DOTA for contrast enhanced MRI of intracranial tumours Neuroradiology 46 2004 655 665
11. D. Baleriaux, C. Colosimo, and J. Ruscalleda et al. Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine Neuroradiology 44 2002 191 203
12. L.A. Carbonaro, F. Pediconi, and N. Verardi et al. Breast MRI using a high-relaxivity contrast agent: an overview AJR Am J Roentgenol 196 2011 942 955
13. L. Martincich, M. Faivre-Pierret, and C.M. Zechmann et al. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial) Radiology 258 2011 396 408
14. F. Sardanelli, A. Fausto, and A. Esseridou et al. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance Invest Radiol 43 2008 236 242
15. L.A. Carbonaro, N. Verardi, and G. Di Leo et al. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement Invest Radiol 45 2010 114 120
16. F. Sardanelli, M.G. Hunink, F.J. Gilbert, G. Di Leo, and G.P. Krestin Evidence-based radiology: why and how? Eur Radiol 20 2010 1 15